Logo
DCA

Repligen Corporation

RGENHealthcareMedical Instruments & Supplies
147,25 $US
-0.88%
Dernier cours
147,25 $US
2026-07-17
Variation 24h
-0.88%
-1.30 USD
Volume
906 k
Titres échangés
Fiabilité des données
Forte
10132 points (40 ans)

Évolution du cours

Lancer une simulation avec cet actif

RGEN

Paramètres globaux

Données disponibles du 29/04/1986 au 17/07/2026

Analyse Fondamentale

New
CAGR (5y)
-2.70%
Revenue Growth
Net Margin
6.62%
Profitability
ROE
2.32%
Return on Equity
Debt / EBITDA
3.81
Solvency
PEG Ratio
2.08
Valuation vs Growth
Rev. Growth (TTM)
14.80%
Current Trend

Historique PER (5 ans)

Historical PE
Average (137.1x)
Current: 145.1x
Focus technique
RGEN
Volatilité 30j
74.86%
Écart MA50
14.67%
Écart MA200
5.09%
Écart ATH
-54.58%
Momentum 3M
12.22%
Score de risque
N/A

Volatilité modérée. Momentum neutre.

À propos de Repligen Corporation

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Investir cet actif
Acheter via Saxo Banque
🏦Courtier régulé (AMF)
🌍Accès marchés globaux
📈Outils professionnels

Lien commercial. Investir comporte des risques.

Analyse Technique & Risque

Metrics Clés

CAGR6.61%
Volatilité74.86%
Max Drawdown-50.64%

Momentum : RGEN

Indicateur synthétique
PEURNEUTREAVIDITÉ
52
Neutral

Analyse Risque

VaR (95%)-6.45%
Santé DCA
61/100

Historique récent (60 jours)

DateClôtureVolume
2026-07-17147,25 $US905 639
2026-07-16148,55 $US823 057
2026-07-15148,06 $US860 821
2026-07-14147,13 $US519 193
2026-07-13144,88 $US740 660
2026-07-10144,24 $US457 326
2026-07-09143,94 $US667 198
2026-07-08137,41 $US689 000
2026-07-07139,83 $US617 800
2026-07-06141,46 $US637 003
2026-07-02142,40 $US981 602
2026-07-01138,99 $US1 161 912
2026-06-30136,44 $US1 089 095
2026-06-29137,00 $US1 759 316
2026-06-26147,01 $US1 875 150
2026-06-25145,23 $US1 894 214
2026-06-24138,40 $US1 372 856
2026-06-23126,37 $US837 184
2026-06-22126,57 $US810 533
2026-06-18132,02 $US1 217 163
2026-06-17133,55 $US1 315 838
2026-06-16131,69 $US577 074
2026-06-15130,87 $US562 114
2026-06-12130,59 $US1 269 638
2026-06-11133,33 $US623 451
2026-06-10130,76 $US1 203 877
2026-06-09130,13 $US1 466 588
2026-06-08125,33 $US741 320
2026-06-05122,31 $US672 581
2026-06-04126,55 $US982 636
2026-06-03121,73 $US650 590
2026-06-02121,13 $US737 914
2026-06-01123,10 $US654 931
2026-05-29123,95 $US823 724
2026-05-28122,73 $US1 425 481
2026-05-27113,17 $US1 125 500
2026-05-26115,19 $US787 000
2026-05-22115,06 $US714 436
2026-05-21113,37 $US990 913
2026-05-20111,74 $US1 164 132
2026-05-19108,52 $US2 199 779
2026-05-18104,20 $US1 547 665
2026-05-15102,87 $US2 307 248
2026-05-14103,38 $US2 010 732
2026-05-13107,03 $US1 660 291
2026-05-12113,60 $US1 454 864
2026-05-11115,91 $US1 283 636
2026-05-08123,46 $US924 244
2026-05-07126,43 $US935 806
2026-05-06125,76 $US1 625 385
2026-05-05125,61 $US2 065 504
2026-05-04118,21 $US1 280 562
2026-05-01117,20 $US751 851
2026-04-30118,31 $US1 609 810
2026-04-29113,11 $US852 039
2026-04-28117,43 $US726 060
2026-04-27118,29 $US779 099
2026-04-24117,60 $US1 234 335
2026-04-23114,06 $US2 165 393
2026-04-22124,40 $US1 016 244

Actifs Relatifs